Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.2K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

461
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
461
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biologic effectiveness increases with earlier biologic initiation after severe asthma onset.

The journal of allergy and clinical immunology. Global·2026
Same author

The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

The journal of allergy and clinical immunology. Global·2026
Same author

Reply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.

American journal of respiratory and critical care medicine·2026
Same author

Improved asthma outcomes for dupilumab plus medium-dose inhaled corticosteroids versus placebo plus high-dose inhaled corticosteroids.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Tezepelumab in Real-World U.S. Patients with Severe Asthma Across Phenotypes and Underrepresented Populations: The Phase 4 PASSAGE Study.

American journal of respiratory and critical care medicine·2026
Same author

Mortality Among Adults with Subspecialist-Treated Severe Asthma: A Descriptive Analysis from the Observational CHRONICLE Study.

Journal of asthma and allergy·2026

Related Experiment Video

Updated: Jul 26, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K

Mild asthma: Lessons learned and remaining questions.

Arjun Mohan1, Njira L Lugogo1

  • 1Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.

Respiratory Medicine
|June 16, 2023
PubMed
Summary
This summary is machine-generated.

Mild asthma patients are diverse and at risk for poor outcomes. Research needs to identify phenotypes and risk factors to improve management beyond short-acting beta-agonist reliance.

Keywords:
Future researchInflammationManagementMild asthmaRisks

More Related Videos

Asthma Detection Research Based on Voice Signal Processing and Machine Learning
04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

7
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.7K

Related Experiment Videos

Last Updated: Jul 26, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.0K
Asthma Detection Research Based on Voice Signal Processing and Machine Learning
04:04

Asthma Detection Research Based on Voice Signal Processing and Machine Learning

Published on: July 22, 2025

7
Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

27.7K

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Clinical Immunology

Background:

  • Mild asthma constitutes the largest patient group, yet defining it and identifying at-risk individuals remains challenging.
  • Significant inflammatory and clinical heterogeneity exists within the mild asthma population.
  • Mild asthma patients face risks including poor disease control, exacerbations, lung function decline, and mortality.

Purpose of the Study:

  • To highlight the heterogeneity and risks associated with mild asthma.
  • To emphasize the need for better phenotyping and understanding of disease progression factors.
  • To advocate for updated management strategies prioritizing inhaled corticosteroids over short-acting beta-agonists.

Main Methods:

  • Literature review and synthesis of current research on mild asthma.
  • Analysis of existing data on inflammatory markers, clinical presentation, and treatment outcomes.
  • Discussion of current clinical practice guidelines and their adherence.

Main Results:

  • Eosinophilic inflammation is a potential predictor of poorer outcomes in mild asthma, despite conflicting prevalence data.
  • Disease progression and remission rates vary significantly in mild asthma.
  • Short-acting beta-agonist (SABA) use remains prevalent despite evidence supporting inhaled corticosteroid-based therapies.

Conclusions:

  • There is an urgent need to define phenotypic clusters and identify factors influencing disease progression in mild asthma.
  • Future research should focus on biomarkers, composite risk scores, and targeted therapies for at-risk individuals.
  • Management strategies must evolve to reduce reliance on SABAs and adopt evidence-based, inhaled corticosteroid-centered approaches.